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Background: Skeletal muscle power is velocity-dependent under constant load conditions. Interferon (IFN)-γ is an
inflammatory cytokine that regulates skeletal muscle recovery following insult in experimental animals. It is
unknown if the power-velocity relationship and IFN-γ are modulated after a muscle-damaging event in humans.
Therefore, the purpose of this study was to identify the power-velocity relationship and circulating IFN-γ
concentration responses to a muscle-damaging event in humans.
Methods: Nine healthy males participated in this study. Each subject had one leg randomly assigned as the control
leg. The other leg served as the treatment leg and performed an intense-stretch-shortening cycling (SSC) exercise
protocol to induce muscle damage. To measure muscle damage and the power-velocity relationship, unilateral
peak isometric force and power output (forces and velocities) measurements were performed prior to, immediately
after, and during the days following the SSC protocol. The circulating IFN-γ concentrations were measured in serum
samples obtained prior to, immediately after, and during the days following the SSC protocol. Statistical significance
of single-leg isometric force and power output data were assessed using a two-way (time and leg treatment)
analysis of variance (ANOVA) with repeated measures, followed by a Tukey’s honestly significant difference (HSD) to
test multiple pairwise comparisons. The statistical significance of the IFN-γ data were assessed using a one-way
(time) ANOVA with repeated measures, followed by a Tukey’s HSD to test multiple pairwise comparisons.
Results: In the treatment leg, significant (P < 0.05) peak isometric force deficits occurred immediately and persisted
several days after the SSC protocol, thereby identifying muscle damage-induced weakness. During muscle weakness
in the treatment leg, peak power was significantly (P < 0.05) depressed and the velocities at peak power were
significantly (P < 0.05) slower. Interestingly, circulating IFN-γ concentrations decreased at 2 and 3 days after
compared to those immediately following the SSC protocol.
Conclusion: We conclude that the velocity to achieve a compromised peak power is reduced, and speculatively,
the circulating IFN-γ excursion could be influential on the recovery of skeletal muscle after a muscle-damaging
event in humans.
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Figure 1 Peak isometric force, velocity at peak power, and
peak power output data. (A) Single-leg peak isometric force
(Newton per kilogram), (B) velocity at peak power (meters per
second), and (C) peak power output (watts per kilogram) data prior
to and following the SSC protocol 1, P < 0.05 vs. Bsl; 2, P < 0.05 vs.
Pre; 3, P < 0.05 vs. 24 h; 4, P < 0.05 vs. 48 h; 5, P < 0.05 vs. 72 h; 6,
P < 0.05 vs. 168 h. *P < 0.05 vs. corresponding CON. Legend
provided in (A). Data presented as mean ± standard error of mean
(SEM).
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Skeletal muscle power is an important determinant of
human locomotion. Skeletal muscle power production is
velocity-dependent, and therefore, should be interpreted in
relation to the velocity of the movement required to pro-
duce peak power [1-3]. Although the power-velocity rela-
tionship is a fundamental principle in muscle physiology,
surprisingly, human studies examining this relationship
during multi-joint movements that resemble locomotive
activities are limited, especially during skeletal muscle
weakness and soreness induced by muscle damage. Muscu-
lar weakness induced by a damaging event (i.e., muscle
damage-induced weakness) is a unique measure of re-
habilitation because it spans the degenerative and regen-
erative biological processes that govern recovery [4].
Millions of people worldwide every year are affected by
muscle weakness induced by a damaging event, which can
be mediated by a variety of conditions, including intense or
exhaustive stretch-shortening cycling (SSC) contractions.
SSC contractions are characterized by repetitive skeletal
muscle lengthening (eccentric) and shortening (concentric)
contraction cycles, with the former of the contraction mo-
dalities being the dominate mediator of muscle damage.
SSC contractions also serve as an excellent model for
studying neuromuscular performance [5,6]; in leg muscles,
examples of SSC contractions include walking, running,
sprinting, and jumping. Compared to ultra-structure
disturbances in skeletal muscle and circulating protein altera-
tions, immediate (minutes-to-hours) peak isometric deficits
that persist for days, such as those after exhaustive SSC con-
tractions, is a reliable indicator of muscle damage [4].
Inflammatory cytokines are small proteins secreted from
nearly every nucleated cell in the body, and importantly,
pro- and anti-inflammatory cytokines are essential for
skeletal muscle regeneration following a damaging event
[7]. Interferon (IFN)-γ is a cytokine that possesses pro-
and anti-inflammatory properties [8], and provocatively,
its anti-fibrotic and proliferative properties promote
muscle healing and the recovery in skeletal muscle func-
tion after insult in experimental animals [9,10]. Despite
animal studies showing a potential role of IFN-γ on the
influence of skeletal muscle recovery, there is little evi-
dence identifying the circulating IFN-γ response to muscle
damage in humans [11,12].
Therefore, based on the aforementioned gaps in our know-
ledge, the primary aim of this study was to identify the
power-velocity relationship during persistent peak isometric
force deficits induced by intense SSC exercise. We hypothe-
sized that there would be a down- and left-ward shift in
the power-velocity relationship during muscular weakness
induced by a muscle-damaging event. The secondary aim of
this study was to measure circulating IFN-γ alterations after
a muscle-damaging event. We hypothesized that IFN-γ
would decrease after a muscle-damaging event in humans.Results
Isometric force
There was a significant (F = 13.368 (1,6) P < 0.05) treat-
ment per time interaction in peak isometric forces (Newton
per kilogram; Figure 1A). Peak isometric forces were not
significantly changed in the control (CON) leg. In contrast,
peak isometric forces in the SSC leg were significantly
decreased (P < 0.05) (i.e., Post; approximately 28%) immedi-
ately and shortly after the SSC protocol (48 h (approxi-
mately 19%) and 72 h (approximately 13%) compared to
those prior to the SSC protocol (i.e., Bsl and Pre). Immedi-
ately following the SSC protocol (i.e., Post), peak isometric
forces were significantly (P < 0.05) decreased compared to
those at 24, 72, and 168 h. At 48 h peak isometric forces
were significantly (P < 0.05) decreased compared to those
at 168 h in the SSC leg. Furthermore, peak isometric forces
in the SSC leg were significantly (P < 0.05) decreased at
Post (approximately 24%), 24 h (approximately 12%), 48 h
(approximately 21%), and 72 h (approximately14%) com-
pared to those in the CON leg. Thus, peak isometric force
deficits persisted days after the SSC protocol, thereby
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muscle damage.
Velocity at peak power
A significant (F = 3.81 (1,6) P < 0.05) treatment per time
interaction was observed in the velocities (meters per
second) at peak power (Figure 1B). Velocities at peak
power were not significantly changed in the CON leg.
Velocities at peak power were significantly (P < 0.05)
slower in the SSC leg at Post compared to all other time
points. At 72 h, velocities at peak power were signifi-
cantly (P < 0.05) slower compared to those at Pre in the
SSC leg. Velocities at peak power were also significantly
(P < 0.05) different between the SSC and CON legs at
Post and 72 h. These data indicate an immediate and a
secondary slowing in velocities at peak power after an
intense SSC contraction protocol.
Peak power output
There was a significant (F = 8.08 (1,6) P < 0.05) treat-
ment per time interaction in peak power outputs (watts
per kilogram; Figure 1C). Peak power outputs were notFigure 2 Example of the concentric velocity-force and power-velocity
data (collected at 200 Hz with a low-pass filter at 10 Hz) that produced pea
provided from one representative subject. For a given force (Newton; for e
but not the CON (B) leg. Regarding the power-velocity relationship, power
leg. Velocities at peak powers were decreased after the SSC protocol in thesignificantly changed in the CON leg. Conversely, peak
power outputs were significantly (P < 0.05) decreased
after (Post, 24, and 48 h) compared to those immediately
before (Pre) the SSC protocol in the SSC leg. Immedi-
ately after the SSC protocol (Post), peak power outputs
were significantly (P < 0.05) decreased compared to
those at Bsl (approximately 33%), 24, 48, 72, and 168 h
in the SSC leg. The SSC leg peak power outputs were
significantly (P < 0.05) decreased compared to those in
the CON leg at Post (approximately 29%), 48 h (approxi-
mately 14%), and 72 h (approximately11%).Velocity-force and power-velocity relationship
Examples of the concentric velocity-force and power-velocity
relationships for one subject are provided in Figure 2. As
illustrated for this subject, but consistent for all subjects
(data not shown), velocities at a given submaximal force
(e.g., 500 N) were decreased immediately and the first few
days after the SSC protocol in the SSC (Figure 2A), but
not the CON leg (Figure 2B). Furthermore, velocities at
peak powers were decreased after the SSC protocol in the
SSC (Figure 2C) but not the CON leg (Figure 2D).relationship data. The concentric force-velocity relationship jump
k power at each time point for the SSC (A) and CON (B) leg are
xample, at 500 N), velocity (meters per second) varied in the SSC (A)
(W) varied as a function of velocity in the SSC (C) but not the CON (D)
SSC (C), but not the CON leg (D). Figure legend provided in (A).
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There were significant treatment per time interactions in
the gluteus (F = 10.54 (1,6) P < 0.05; Figure 3A), quadri-
cep (F = 11.0 (1,6) P < 0.05; Figure 3B), and hamstring
(F = 2.88 (1,6) P < 0.05; Figure 3C) soreness, and signifi-
cant main effects of time (F = 3.55 (1,6) P < 0.05) and
treatment (F = 5.69 (1,6) P < 0.05) in calve soreness
(Figure 3D). No significant differences in the perceived
muscular soreness were observed in the CON leg for
any muscle group. However, the perceived level of soreness
of the gluteus in the SSC leg was significantly (P < 0.05)
increased at Post (vs. Bsl and 168 h), 24 h (vs. Bsl, Pre, Post,
72 h and 168 h), and 48 h (vs. Bsl, Pre and 168 h).
Perceived gluteus soreness in the SSC leg was signifi-
cantly (P < 0.05) increased compared to those in theFigure 3 Perceived level of gluteus, quadricep, hamstring, and
calf soreness. Perceived level of gluteus (A), quadricep (B),
hamstring (C), and calf (D) soreness (centimeters) prior to and
following the SSC protocol. 1, P < 0.05 vs. Bsl; 2, P < 0.05 vs. Pre; 3,
P < 0.05 vs. Post; 4, P < 0.05 vs. 24 h; 5, P < 0.05 vs. 48 h; 6, P < 0.05
vs. 72 h; 7, P < 0.05 vs. 168 h; *P < 0.05 vs. corresponding CON.
Legend provided in (A). Data presented as mean ± SEM.CON leg at Post, 24 and 48 h. Perceived quadricep sore-
ness in the SSC leg was significantly (P < 0.05) increased
at Post (vs. Bsl), 24 h (vs. Bsl, Pre and 168 h), 48 h (vs.
Bsl, Pre and 168 h), and 72 h (vs. Bsl). Soreness in the
SSC leg was also significantly (P < 0.05) greater than
those in the CON leg at Post, 24, 48, and 72 h.
The hamstring soreness was significantly (P < 0.05)
increased at Post and 24 h (both vs. Bsl and 168 h) in the
SSC leg compared to the corresponding values in the
CON leg. Perceived calve soreness significantly (P < 0.05)
increased at Post and 24 h (both vs. Bsl and 168 h) in the
SSC leg and in the SSC leg compared to CON leg at 24 h.
Taken collectively, the data indicate immediate muscular
soreness that persisted for several days after intense SSC
contractions.Circulating cytokine data
We did not observe a significant change in tumor necro-
sis factor (TNF)-α (Table 1). However, IFN-γ was signifi-
cantly (F = 3.58 (7) P < 0.05) decreased at 48 and 72 h
compared to that at Post (Table 1).Discussion
Previous investigations report power output disturbances
during muscle damage-induced weakness [13-20]. In the
present report, we extend those findings by identifying
concomitant peak power and velocity at peak power
decreases during persistent muscular weakness and sore-
ness after intense SSC contractions. These unique and
impactful findings identify that the human body sacri-
fices the speed of a movement to accomplish a dimin-
ished power output after a muscle-damaging event.
Additionally, we found a small but significant IFN-γ de-
crease after the SSC protocol, plausibly suggesting that
the circulating cytokine excursion could be influential
on the recovery of skeletal muscle after a muscle-
damaging event in humans.Table 1 Cytokine concentrations (picograms per milliliter)
TNF-α IFN-γ
Bsl 5.35 ± 2.94 21.5 ± 9.8
Pre 6.84 ± 3.05 21.9 ± 9.8
Post 5.48 ± 2.94 25.4 ± 11.5*
1 h 5.73 ± 2.64 19.6 ± 8.8
24 h 5.77 ± 2.77 19.5 ± 8.6
48 h 4.97 ± 2.19 17.3 ± 7.8
72 h 3.33 ± 1.43 18.3 ± 8.2
168 h 3.89 ± 1.61 22.5 ± 10.3
*Significantly (P < 0.05) different from 48 and 72 h; data presented as mean ±
SEM.
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was that power outputs were measured under constant
load conditions. This enabled us to assess velocity and
to extend the velocity-dependent data obtained from iso-
lated muscle research to human movement. Using this
methodology, we provide original data identifying vel-
ocity at peak power slowing immediately and again 3
days after the SSC protocol (Figure 1B) and during a
multi-joint movement. Several investigations previously
report various velocity results after intense SSC exercise
[14,16,18,21-24]. For example, the take-off velocity
decreases during rebound drop jumps from various
heights after intense exercise [14,24]. Although these
velocities are a close approximation of the velocity at
peak power, velocities were not temporally aligned to
peak power. Recently, Power et al. [25] provided compel-
ling data illustrating a velocity-dependent power loss fol-
lowing eccentric contractions of the ankle dorsiflexors in
humans. However, outcome measures were completed
30 min after the eccentric contractions. Therefore, con-
clusions regarding velocities at peak power during per-
sistent muscular weakness after a muscle-damaging
event have not been explicitly delineated in humans,
until now. For the first time, we demonstrate velocity at
peak power decreases after a muscle-damaging event in
humans. This velocity at peak power decrease occurred
concomitantly with a decrease in peak power, and thus,
establishing a down- and left-ward shift in the power-
velocity relationship following a muscle-damaging event.
The down- and left-ward shift in the power-velocity
relationship is a unique finding of this study. Although it
is beyond the scope of the present investigation, several
fatigue- and damage-related mechanisms could be re-
sponsible for the velocity at peak power slowing. First,
fatigue-related byproducts (i.e., inorganic phosphate, ad-
enosine diphosphate, and acidosis) increase following a
damaging event [26-29] and impair contractile shorten-
ing velocity in skeletal muscle fibers obtained from
experimental animals [30-32]. Second, low-frequency
torque depressions reflect a disruption in excitation-
contraction coupling [33,34] and occur with shortening
velocity slowing in the human tibialis anterior [25].
Third, fast muscle fibers are regarded as the predomin-
ant fiber type susceptible to muscle damage [35,36]. In
theory, damage to fast fibers should slow shortening
velocity in skeletal muscles composed of heterogeneous
fibers. Finally, inflammatory-derived mediators could be
modulating velocity after a muscle-damaging event. For
example, the pro-inflammatory cytokine, TNF-α, has
been found to impede skeletal muscle shortening vel-
ocity in experimental animals [37]. However, in the
present study, we did not observe a significant TNF-α
increase in the circulation, and local concentrations were
not measured. Given the preponderance of evidenceidentifying a localized pro-inflammatory response fol-
lowing a muscle-damaging event [12,33,38,39] and tak-
ing into consideration the muscle soreness reported in
the SSC leg by our subjects (Figure 3A-D), it is plausible
that a localized pro-inflammatory response, among other
mediators, is contributing to the velocity impairments
during muscular weakness after a damaging event.
An intriguing finding in the present investigation was
the subtle fluctuation in IFN-γ days after a muscle-
damaging event in humans (Table 1). Few studies have
investigated the influence of a muscle-damaging event
or exhaustive exercise on IFN-γ. In athletes, serum IFN-
γ concentrations remained constant, but in whole blood
culture, lipopolysaccharide-induced production of IFN-γ
was abolished after exhaustive exercise (sprint triathlon
under competitive conditions) [11]. In physically active
subjects, serum IFN-γ concentrations were not signifi-
cantly different following uphill or downhill running
[12]. These previous studies suggest no change or de-
crease in IFN-γ following exhaustive or eccentrically
biased exercise [11,12]. Herein, serum IFN-γ concentra-
tions were decreased at 48 and 72 h compared to those
immediately after intense SSC exercise (Table 1). Al-
though no significant increase in serum IFN-γ was
observed immediately following the SSC exercise, our
findings extend previous reports [11,12] by illustrating a
time-sensitive decrease in concentrations 2 and 3 days
following exercise. This finding warrants additional re-
search for future resolve since this is the first study illus-
trating a decrease in serum IFN-γ concentrations after
an acute muscle-damaging event in humans.
Lymphocytes and natural killer (NK) cells are major
sources of IFN-γ [40]. In damaged skeletal muscle, IFN-
γ expression is time-sensitive and correlates with the ac-
cumulation of T-cells, macrophages, and NK cells [9].
We speculate that the later circulating IFN-γ decrease is
the result of immune cells migrating from the circula-
tion to the site of localized trauma in the skeletal muscle
after a damaging event.
In skeletal muscle IFN-γ could contribute to the early
regenerative process. For example, neutralizing anti-
bodies against the IFN-γ receptor lowered C2C12 muscle
cell proliferation after injury, suggesting that the pres-
ence of IFN-γ contributes to proliferation [9]. However,
contrasting results exist in vitro, which specifically indi-
cate that IFN-γ inhibits C2C12 and myoblast prolifera-
tion and differentiation [41]. These in vitro discrepancies
could, potentially, be explained by disparate IFN-γ con-
centrations [42], as low concentrations promote [43] and
high concentrations inhibit [44] satellite cell prolifera-
tion. Based on the conflicting reports in the literature, it
is unclear if the present fluctuations in serum IFN-γ
concentrations were beneficial on the skeletal muscle
following a damaging event.
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tion. First, subjects performed the SSC contractions as
fast as possible and jumped as high as possible under
constant load conditions. Under constant load condi-
tions, external resistance is variable through a range of mo-
tion, which could alter the precise intensity of the muscle
contraction within and between our subjects. Future stud-
ies utilizing a dynamometer are encouraged. Secondly,
muscle biopsies were not obtained to assess localized
microtrauma. However, muscle damage is reliably identi-
fied by persistent (days) peak isometric force deficits fol-
lowing intense SSC contractions [13,14,21,24,45-47].
Therefore, based on our peak isometric deficits that per-
sisted for several days (Figure 1A), we believe that our SSC
exercise protocol induced muscle damage as opposed to
fatigue where peak isometric forces would have recovered
rapidly [4]. However, it is likely that our high-intensity ex-
ercise protocol, which involved minimal inter-set rest,
mediated both muscle fatigue and damage. We speculate
that fatigue could have contributed to muscular weakness
immediately following the intense exercise protocol, but
again, based on the persistent force deficits, damage-
related events could be the dominating factors contributing
to muscular weakness days after the intense exercise proto-
col. Next, cytokine data was variable (Table 1). In order to
account for this variability statistically, we performed a
rank transformation to achieve normality and equal vari-
ance. Finally, cytokine data was limited to circulating mea-
sures. Future studies are encouraged to examine circulating
and local inflammatory cytokine challenges, and to identify
if these challenges influence the recovery in skeletal muscle
function after a muscle-damaging event.
Conclusions
Revealing the influence of a muscle-damaging event on
the velocity at peak power has significant implications on
locomotion, physical performance, and physical rehabilita-
tion in diverse pathophysiological and physiological condi-
tions in humans. In the present investigation, we provide
unique results illustrating concomitant decreases in peak
power and the velocity at peak power after a muscle-
damaging event in humans. This down- and left-ward shift
in the power-velocity relationship occurred during a circu-
lating decrease in IFN-γ, an inflammatory cytokine that
regulates skeletal muscle recovery. These findings are of
clinical and practical relevance because they identify that
muscle damage slows the velocity at which a compro-
mised peak power occurs, and importantly, that the recov-
ery in skeletal muscle after a damaging event could be
influenced by IFN-γ. Thus, in humans, we conclude that
muscle damage mediates a velocity-dependent loss in peak
power and that the recovery in skeletal muscle function
after a muscle-damaging event could be related to a cyto-
kine that possesses anti-fibrotic and proliferative properties.Methods
Participants
The Institutional Review Board at Intermountain Health-
care (Salt Lake City, UT, USA) approved this study. Sub-
jects were informed of and provided written and verbal
consent to the experimental protocol and procedures.
Based on our pilot studies and the primary aim of this
study, in order to detect an 18% difference between peak
power output means within the SSC leg from Pre to 48 h
with a statistical power of 90% at an α = 0.05 at least six
subjects were required. However, anticipating that some
subjects may not complete the protocol, we therefore
recruited and enrolled nine healthy, recreationally active
(i.e., 30 min of continuous physically active at least three
times per week) males (age, 33 ± 2 years; height, 182 ±
2 cm; 89 ± 4.1 kg; body mass index, 26.9 ± 1.1 kg/m2)
to participate in this study. Subjects were excluded if they
were taking any dietary supplements, anti-inflammatory
medication(s), and/or suffered a lower leg injury during
the previous year that required the use of crutches. Sub-
jects were also excluded if strength asymmetry (>5% dif-
ference in peak isometric force or power output) was
present between legs. The symmetry in leg strength was
important since all strength testing and the SSC protocol
were performed unilaterally and statistical comparisons
were made within and between legs. Thus, differences in
leg strength upon study enrollment could be a confound-
ing factor.
SSC protocol
Upon study enrollment, each subject had one leg ran-
domly assigned as the CON leg. The other leg served as
the treatment (SSC) leg and performed an intense SSC
protocol. The rationale for performing this protocol uni-
laterally was to assess isometric force and power output
outcomes within and between legs across time.
Based on our preliminary experiments to establish a
protocol that induces persistent peak isometric force
deficits and to measure power output using the same
multi-joint modality for inducing muscle damage, each
subject performed an SSC protocol that consisted of ten
sets of ten repetitive jumps at 75% of body mass with a
20 s rest between each set (Figure 4). Subjects were
instructed and verbally encouraged to perform each set
with maximal effort and to jump as-high-as possible
through a full range of motion (90° of knee flexion-to-
full extension) during the SSC protocol. If subjects were
no longer able to complete two successive jumps, sub-
jects were then allowed to perform presses through a full
range of motion (90° of knee flexion-to-full extension). It
should be noted that switching from jumps to presses
presumably lowered the eccentric magnitude during
loading. If subjects were unable to complete the presses,
the exercise protocol was terminated. The mean number
Figure 4 Example of single-leg strength testing on the horizontal Plyo-press. (A) During single-leg peak isometric testing, the weight stack
was overloaded. Overloading the weight stack prevented sled movement, thereby allowing for an isometric contraction. (B) Subjects performed
repeated jumps during the single-leg jump tests. Illustrated is an example of a concentric Plyo-press jump from push-off (A) to peak height (B).
Weight stack resistance was set at 75% of body mass.
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were 73 ± 10 and 15 ± 5, respectively, while three of the
nine subjects were unable to complete the SSC protocol.
Analytical procedures
Single-leg strength testing
Single-leg peak isometric force and power output mea-
surements were performed on seven different occasions:
1) baseline (Bsl; 28-d before the SSC protocol); 2) imme-
diately before (Pre) the SSC protocol; and 3) immedi-
ately (Post), 4) 24, 5) 48, 6) 72 and 7) 168 h (7-d) after
the SSC protocol.
All single-leg strength testing was performed on a hori-
zontal Plyo-press (Athletic Republic, Park City, UT, USA)
(Figure 4). Plyo-press output data were measured from
signals obtained from a force plate (Advanced Mechanical
Technology, Watertown, MA, USA) mounted to the foot-
plate of the Plyo-press and from a displacement trans-
ducer (UniMeasure PA-50-NJC, Corvallis, OR, USA)
attached to the weight stack. All data were sampled at 200
Hz with a low-pass filter at 10 Hz using DartPower soft-
ware (Athletic Republic, Park City, UT, USA, version 2.0).
Before every testing session, subjects performed a self-
selected warm-up, and the mounted force plate was
zeroed without any external force (i.e., without anyone
touching the mounted force plate) and then load cali-
brated at 75% of the subjects body mass (i.e., with the
subject on the Plyo-press in a fully extended position
and the weight stack resistance set at 75% body mass).
For the single-leg isometric force measurements, the
Plyo-press sled was adjusted for each subject to align the
knee and hip joint flexion angles to 90°, while the knee
joint flexion angle subsequently standardized foot pos-
ition on the force plate across testing days. The Plyo-
press sled position was documented and reproduced to
achieve the desired knee and hip joint flexion angles at
the follow-up visits. Hip and knee extension-isometriccontractions were elicited by overloading the weight
stack resistance (>2,260 N). Each subject performed
three maximal single-leg isometric contractions. The leg
selection at the start of each testing session was rando-
mized and subsequently followed by an alternating se-
quence of leg contractions. Each isometric contraction
was 3 s in duration and separated by approximately 1
min of rest. Subjects were verbally instructed and
encouraged to exert maximal force against the mounted
force platform. Peak isometric force was defined as the
highest resultant force applied during the 3 s test and
was expressed relative to body mass (Newton per
kilogram).
Given the variability in human performance testing
and to assess the reproducibility of the effort provided
by our subjects, the peak isometric force coefficients of
variation at each testing session in each leg were calcu-
lated (Additional file 1: Table S1). The coefficient of var-
iations indicated good reliability within each leg at each
testing visit. Further, the intra-class reliability coefficient
for the peak isometric forces in the CON leg was 0.98,
thereby establishing reliability within the CON leg across
time. We did not calculate the intra-class reliability coef-
ficient within the SSC leg because peak isometric forces
were modulated following the muscle-damaging event,
and thus, would influence the reliability calculation.
Single-leg peak power output measures followed the
single-leg isometric contractions and were measured on
the same horizontal Plyo-press with the same securing
procedures described above. Starting from an extended
position (full extension = 0°), subjects performed repeti-
tive single-leg jumps (i.e., hip and knee flexion-extension
cycles). Subjects were instructed and verbally encour-
aged to perform the jumps as fast as possible and
through a full range of motion (90° of knee flexion-to-
full extension). Each test was 20 s (mean number of
jumps, 0 jumps/20 s test; range from 9 to 12 jumps/20 s
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75% of body mass (66.2 ± 3.1 kg). The time-aligned
product of the resultant force (Newton) acquired from
the force platform and weight stack velocity (meters per
second) data obtained from the displacement transducer
were used to calculate power output. The peak power
output was defined as the highest power output pro-
duced during the 20 s test for each leg, and the velocity
at that peak power was recorded.
To assess the reliability of the jump tests and to deter-
mine if subjects were providing consistent effort with
each jump at each testing session, the intra-test coeffi-
cients of variation for peak powers were calculated for
the CON and SSC legs (Additional file 1: Table S1). The
intra-test coefficients of variation were good for each leg
at each testing visit. The intra-class reliability coefficient
for peak power output within the CON leg was 0.96, in-
dicating reliability within the CON leg across time. Simi-
lar to peak isometric forces, we did not calculate the
intra-class reliability coefficient in the SSC leg because
power outputs vary with muscle damage, and are there-
fore, inconsistent.
Muscle soreness
Subjects rated their perceived soreness in the gluteus,
quadriceps, hamstrings, and calves in each leg. Perceived
soreness measures were performed prior to all strength
testing sessions and immediately after the SSC protocol.
Specifically, subjects rated their perceived level of sore-
ness at Bsl, Pre, Post, 24, 48, 72, and 168 h.
To assess perceived muscular soreness, subjects low-
ered their bodies into a squat position (90° of hip and
knee flexion) for 5 s while resting their back against a
wall. This was repeated three times at each visit. In the
squat position, subjects rated their perceived level of
soreness in the gluteus, quadriceps, hamstrings, and
calves on each leg by using a visual analog scale (10 cm
in length) of 0 to 10, with 0 being ‘no pain’, 10 being the
‘worst possible pain’ and 5 being ‘tender to touch but
not to contractions’ [48]. Subjects made a perpendicular
mark on the visual analog scale from which perceived
soreness was quantified by measuring to the nearest
tenth of a centimeter. The intra-class reliability coeffi-
cients for the gluteus, quadriceps, hamstrings, and calves
in the CON leg were 0.93, 0.83, 0.90 and 0.93,
respectively.
Serum cytokines
Each subject provided eight fasting blood draws: 1) base-
line (Bsl; 28-d before the SSC protocol); 2) immediately
before (Pre) the SSC protocol; and 3) immediately (Post),
4) 1 h, 5) 24 h, 6) 48 h, 7) 72 h and 8) 168 h after the
SSC protocol. Blood samples were obtained from the
antecubital vein into one 6.0 ml serum Becton DickinsonVacutainer tube (Franklin Lakes, NJ, USA). Serum was
separated by centrifugation (VWR International, Radnor,
Pennsylvania, Clinical 50 Centrifuge) at 1,068 g for 20
min, within 20 min of sample collection and coagulation.
Serum samples were immediately stored at −80°C (Revco
Freezer, GC Laboratory Equipment, Asheville, NC, USA)
until the day of cytokine concentration analyses. All
blood draws were obtained immediately before strength
testing, with the exception of the Post draw that was col-
lected after the SSC protocol and after the Post strength
testing session.
A multiplex microsphere-bead array was used to
measure circulating inflammatory cytokines (picograms
per milliliter) as described previously [49,50]. Briefly,
serum cytokines were quantitated using a multiplexed
sandwich capture assay developed in the ARUP Institute
for Clinical and Experimental Pathology (University of
Utah, Salt Lake City, UT, USA) using the Luminex
Multi-Analyte Profiling system (Luminex, Austin, TX,
USA) [49]. Monoclonal capture antibodies for TNF-α
and IFN-γ were coupled to microspheres (Luminex).
The monoclonal antibody for TNF-α was purchased
from Pharmingen/BD Biosciences (San Diego, CA,
USA), and IFN-γ was purchased from Biosciences (San
Diego, CA, USA). Procedural precision, specificity, and
sensitivity of this multiplex-cytokine bead assay have
been reported previously [49,50].Statistical analyses
To achieve a normal distribution of the data, rank trans-
formations were performed on single-leg strength,
muscle soreness, and cytokine data. Transformations
were checked for normality with the Kolmogorov-
Smirnov test. Statistical significance of the data (single-
leg strength and soreness data) was assessed using a
two-way (time, leg treatment) analysis of variance
(ANOVA) with repeated measures, followed by a Tukey’s
honestly significant difference (HSD) to test multiple
pairwise comparisons. One-way ANOVA was performed
on isometric and power output coefficients of variation
within each leg separately (i.e., CON and SSC leg). The
one-way ANOVA was used to compute the intra-class
reliability coefficients for the single-leg strength testing
(peak isometric and power output) and perceived mus-
cular soreness measurements within the CON leg. Stat-
istical significance of the cytokine data (concentrations
and concentration changes) were assessed using a one-
way (time) ANOVA with repeated measures, followed by
a Tukey’s HSD to test multiple pairwise comparisons.
Data presented as mean ± SEM. All statistical analyses
were performed with SysStat software (SigmaPlot 10.0,
SigmaStat 3.5, Chicago, IL, USA). Statistical significance
was set at a P < 0.05.
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